- Home
- PROK vs PKBK Comparison
PROK vs PKBK Comparison
Compare PROK & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- PKBK
- Stock Information
- Founded
- PROK 2015
- PKBK 1999
- Country
- PROK United States
- PKBK United States
- Employees
- PROK N/A
- PKBK N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- PKBK Major Banks
- Sector
- PROK Health Care
- PKBK Finance
- Exchange
- PROK Nasdaq
- PKBK Nasdaq
- Market Cap
- PROK 206.0M
- PKBK 235.2M
- IPO Year
- PROK N/A
- PKBK N/A
- Fundamental
- Price
- PROK $1.50
- PKBK $19.54
- Analyst Decision
- PROK Buy
- PKBK
- Analyst Count
- PROK 5
- PKBK 0
- Target Price
- PROK $4.50
- PKBK N/A
- AVG Volume (30 Days)
- PROK 344.0K
- PKBK 25.2K
- Earning Date
- PROK 03-21-2025
- PKBK 01-24-2025
- Dividend Yield
- PROK N/A
- PKBK 3.69%
- EPS Growth
- PROK N/A
- PKBK N/A
- EPS
- PROK N/A
- PKBK 2.27
- Revenue
- PROK N/A
- PKBK $62,281,000.00
- Revenue This Year
- PROK N/A
- PKBK N/A
- Revenue Next Year
- PROK N/A
- PKBK N/A
- P/E Ratio
- PROK N/A
- PKBK $8.61
- Revenue Growth
- PROK N/A
- PKBK N/A
- 52 Week Low
- PROK $1.34
- PKBK $15.24
- 52 Week High
- PROK $4.44
- PKBK $24.29
- Technical
- Relative Strength Index (RSI)
- PROK 41.47
- PKBK 42.26
- Support Level
- PROK $1.50
- PKBK $19.63
- Resistance Level
- PROK $1.67
- PKBK $20.18
- Average True Range (ATR)
- PROK 0.10
- PKBK 0.47
- MACD
- PROK -0.00
- PKBK 0.02
- Stochastic Oscillator
- PROK 10.71
- PKBK 22.64
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.